Efficacy of microwave ablation and entecavir as a combination treatment for primary liver cancer and their effects on hepatitis B virus and liver function

References

• Global Burden of Disease Liver Cancer C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al. 2017. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 3(12):1683–1691.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, American Association for the Study of Liver D. 2011. Management of hepatocellular carcinoma: an update. Hepatology. 53(3):1020–1022.
   PubMed Web of Science ®Google Scholar
• Chen Q, Chen R, Zeng YX, Wang Y, Zhou FY. 2017. Correlation analysis between HBV-DNA load and HBV serum and liver fibrosis markers in patients with chronic hepatitis B virus infection.
   Google Scholar
• Guo Y, Sun Y, Song P, Yuji AN, Weina HE. 2013. Clinical study of CT-guided percutaneous microwave ablation therapy(PMAT) for lung cancer.
   Google Scholar
• Huang G, Li PP, Lau WY, Pan ZY, Zhao LH, Wang ZG, Wang MC, Zhou WP. 2018. Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels. Ann Surg. 268(6):943–954.
   PubMed Web of Science ®Google Scholar
• Jingzhi YU, Jiancheng W, Wei Z. 2017. Clinical efficacy of TACE combined with entecavir for hepatitis B related primary liver cancer.
   Google Scholar
• Kim YW, Kwon JH, Chung E, Lee SW, Lee JY, Jang JW, Chung KW, Nam SW. 2015. Short term virologic efficacies of telbivudine versus entecavir against hepatitis B-related hepatocellular carcinoma. Gastroenterol Res Pract. 2015:181065.
   Web of Science ®Google Scholar
• Lee J, Yoo SH, Sohn W, Kim HW, Choi YS, Won JH, Heo JY, Park SJ, Park YM. 2016. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B. Clin Mol Hepatol. 22(3):339–349.
   PubMed Web of Science ®Google Scholar
• Leung U, Kuk D, D’Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y. 2015. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 102(1):85–91.
   PubMed Web of Science ®Google Scholar
• Li-Qing B, Juan S. 2017. Diagnostic value of common biochemical indicators of liver function for primary hepatocellular cancer.
   Google Scholar
• Li C, Wu B, Chen X, Duan Z, Tian P. 2015. Study on correlation between HBV Pre-S1 antigen with HBV DNA,HBV M and liver function in patients with hepatitis B.
   Google Scholar
• Liang P, Yu J, Lu MD, Dong BW, Yu XL, Zhou XD, Hu B, Xie MX, Cheng W, He W. 2013. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol. 19(33):5430–5438.
   PubMed Web of Science ®Google Scholar
• Liao JS, Liu Q, Huan-Jun LI, Jia Y. 2017. Effects and safety of Apatinib mesylate in the treatment of advanced primary liver cancer.
   Google Scholar
• Liu J, Meng QX, Cui QC, Yang R, Chen X. 2017. Simple hepatic cysts: comparative study on ultrasound-guided percutaneous puncture lauromacrogol injection and anhydrous ethanol sclerotherapy.
   Google Scholar
• Liu Y, Wu F. 2010. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 118(6):818–824.
   PubMed Web of Science ®Google Scholar
• Lubner MG, Brace CL, Ziemlewicz TJ, Hinshaw J, Lee FT. 2013. Microwave ablation of hepatic malignancy. Semin Intervent Radiol. 30(1):056–066.
   Web of Science ®Google Scholar
• Luo A, Jiang X, Ren H. 2018. Entecavir-based combination therapies for chronic hepatitis B: a meta-analysis. Medicine (Baltimore). 97(51):e13596.
   Web of Science ®Google Scholar
• Marengo A, Rosso C, Bugianesi E. 2015. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 67(67):103.
   Google Scholar
• Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. 2003. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology. 37(5):1114–1121.
   PubMed Web of Science ®Google Scholar
• Meloni MF, Chiang J, Laeseke PF, Dietrich CF, Sannino A, Solbiati M, Nocerino E, Brace CL, Lee Jr. FT. 2017. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia. 33(1):15–24.
   PubMed Web of Science ®Google Scholar
• Mu-Fa C, Feng G, Xiao-Fang FU. 2015. The study on the relationship between AFU and ALT, AST, GGT of serum in liver disease.
   Google Scholar
• Ozakyol A. 2017. Global epidemiology of hepatocellular carcinoma (HCC epidemiology). J Gastrointest Cancer. 48(3):238–240.
   PubMed Web of Science ®Google Scholar
• Peng Q, Xiao B, Cheng T, Tan Y, Zhuoliang LI, Zhouyao YU. 2010. Lamivudine therapy after percutaneous microwave coagultion therapy for patients with primary hepatocellular carcinoma complicated with hepatitis B virus:an analysis of 40 cases.
   Google Scholar
• Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. 2015. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol. 7(8):1054–1063.
   PubMed Web of Science ®Google Scholar
• Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hezode C, Lazaro P, et al. 2014. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat. 21(Suppl. 1):34–59.
   PubMed Web of Science ®Google Scholar
• Saitta C, Tripodi G, Barbera A, Bertuccio A, Smedile A, Ciancio A, Raffa G, Sangiovanni A, Navarra G, Raimondo G, et al. 2015. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int. 35(10):2311–2317.
   Web of Science ®Google Scholar
• Sanada T, Hirata Y, Naito Y, Yamamoto N, Kikkawa Y, Ishida Y, Yamasaki C, Tateno C, Ochiya T, Kohara M, et al. 2017. Transmission of HBV DNA Mediated by Ceramide-Triggered Extracellular Vesicles. Cell Mol Gastroenterol Hepatol. 3(2):272–283.
   Web of Science ®Google Scholar
• Sun HY, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY. 2016. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization. Clin Mol Hepatol. 22(4):458–465.
   Web of Science ®Google Scholar
• Xiao R, Tian H, Xiaodan HU. 2018. Influencing factors of microwave ablation on tumor-free survival rate in treatment of primary liver cancer.
   Google Scholar
• Xie R, Gui L, Huang Q, Xiongfeng BI, Yang J. 2017. The study progress of lamivudine and entecavir for the treatment of patients with HBV reactivation of primary hepatocellular carcinoma(HCC).
   Google Scholar
• Yan-Li MA, Gastroenterology DO. 2017. Clinical study of antiviral treatment in hepatitis B related advanced liver cancer.
   Google Scholar
• Yan D, Yao XS, Gao QZ, Liu DZ, Zeng HY, Li CR, Shi ZH, Guo YJ, Li H. 2015. Application of nucleos (t) ide analogues in transarterial interventional therapy for hepatitis B virus related hepatocellular carcinoma. Chinese Journal of Interventional Imaging and Therapy. 12(5):293–297.
   Google Scholar
• Yu-Feng X, Da-Qiao Z, Jing-Song H, Chun-Shan W, Wei-Chao Z, Zhi-Yi H, De-Ti P, Mu-Min S, Tung-Ting S, Kam-Wah MD. 2018. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China. PLoS One. 13(9):e0203220.
   Web of Science ®Google Scholar
• Yuan G, Airong HU, Yaoren HU, Zeng C, Zhu D, Shi X. 2018. Clinical efficacy and long-term prognosis of entecavir and adefovir dipivoxil in the treatment of compensatory hepatitis B cirrhosis.
   Google Scholar
• Zhang XJ, Chan-Yuan XU, Ying-Xian LI, Tian GJ, Jian JM, Chi XL. 2015. Combined detection of serum indexes of liver function in the differential diagnosis of primary hepatocellular carcinoma and intrahepatic colangiocarcinoma.
   Google Scholar
• Zhang CM, Jing HE, Zhang YX, Zhang XL, Wang Y, Wei GH, Xing XY. 2015. Nursing care for patients with primary liver cancer receiving CT-guided percutaneous microwave ablation treatment.
   Google Scholar
• Zhang MY, Wen ZL, Yan-Hua XU. 2012. Clinical significance of alkaline phosphatase, γ-glutamyl transpeptidase and cholinesterase detection in chronic hepatitis B, liver cirrhosis, hepatocellular carcinoma and biliary tract disease.
   Google Scholar
• Zhang H, Zhou Y, Yuan G, Zhou G, Yang D, Zhou Y. 2015. Antiviral therapy improves the survival rate and decreases recurrences and fatalities in liver cancer patients following curative resection: A meta-analysis. Mol Clin Oncol. 3(6):1239–1247.
   Web of Science ®Google Scholar